Trans-ancestral genome-wide association study of longitudinal pubertal height growth and shared heritability with adult health outcomes.

"availability of data and materials the sitar code used in this study is available at https://github com/dcousminer/egg_sitar and 10 5281/zenodo 10214403 credible set analysis was performed using https://github com/edm1/credible-set-analysis/blob/master/credible_set_analysis py . availability of data and materials the sitar code used in this study is available at https://github com/dcousminer/egg_sitar and 10 5281/zenodo 10214403 credible set analysis was performed using https://github com/edm1/credible-set-analysis/blob/master/credible_set_analysis py . availability of data and materials the sitar code used in this study is available at https://github com/dcousminer/egg_sitar and 10 5281/zenodo"

"availability of data and materials the sitar code used in this study is available at https://github com/dcousminer/egg_sitar and 10 5281/zenodo 10214403 credible set analysis was performed using https://github com/edm1/credible-set-analysis/blob/master/credible_set_analysis py ."

"Declarations Competing interestsDiana L. Cousminer is an employee of and shareholder of GlaxoSmithKline (GSK). Mark McCarthy is employed by Genentech and a holder of Roche stock. John Perry is an employee and shareholder of Adrestia Therapeutics. Christine Frithioff-Bøjsøe is currently employed at Novo Nordisk. This work is unrelated to any activities at these companies. Competing interests Diana L. Cousminer is an employee of and shareholder of GlaxoSmithKline (GSK). Mark McCarthy is employed by Genentech and a holder of Roche stock. John Perry is an employee and shareholder of Adrestia Therapeutics. Christine Frithioff-Bøjsøe is currently employed at Novo Nordisk. This work is unrelated to any activities at these companies."

"Funding Cohort funding can be found in the Supplementary Data. S.F.A.G. is funded by R01 HD056465 and the Daniel B. Burke Endowed Chair for Diabetes Research. K.A.B is funded by the National Institutes of Health (T32HL129982). M.McC is a Wellcome Trust Investigator (funding through 212259/Z/18/Z). K.P. is funded by an Academy of Finland research fellowship (no. 322112). J.P. is supported by the Medical Research Council (Unit programs: MC_UU_12015/2, MC_UU_00006/2). R.M.F. is supported by a Wellcome Senior Research Fellowship (WT220390). S.F. is supported by an MRC (UK) Programme grant (G0802782). I.P. and Z.B. are funded by the Diabetes UK (BDA number: 20/0006307), the European Union’s Horizon 2020 research and innovation programme (LONGITOOLS, H2020-SC1-2019–874739). I.P. is supported by Agence Nationale de la Recherche (PreciDIAB, ANR-18-IBHU-0001), by the European Union through the “Fonds européen de développement regional” (FEDER), by the “Conseil Régional des Hauts-de-France” (Hauts-de-France Regional Council) and by the “Métropole Européenne de Lille” (MEL, European Metropolis of Lille)."